Lipid rafts, KCa/ClCa/Ca2 + channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?

Biochimica et Biophysica Acta - Biomembranes

Volumn 1848, Issue 10, 2015, Pages 2603-2620

  Guéguinou, Maxime ^a,b   Gambade, Audrey ^a,b   Félix, Romain ^a,b   Chantôme, Aurélie ^a,b   Fourbon, Yann ^a,b   Bougnoux, Philippe ^a,b,c   Weber, Günther ^a,b   Potier Cartereau, Marie ^a,b   Vandier, Christophe ^a,b  

^a CHRU de Tours   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Calcium channel; Caveola; Chloride channel; EGFR; Lipid raft; Potassium channel

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FAS ANTIGEN; FAS LIGAND; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYCYSTIN; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN C RECEPTOR; STAT PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; UNINDEXED DRUG; VANILLOID RECEPTOR; ANTINEOPLASTIC AGENT; CALCIUM; CHLORIDE CHANNEL; CONJUGATED LINOLEIC ACID; EGFR PROTEIN, HUMAN; ISOENZYME; MEMBRANE LIPID; OMEGA 3 FATTY ACID; POTASSIUM CHANNEL;

APOPTOSIS; BINDING AFFINITY; BLADDER CANCER; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COLON; ENZYME ACTIVATION; ENZYME DEGRADATION; EXTRACELLULAR CALCIUM; GASTROINTESTINAL STROMAL TUMOR; GLIOMA; HUMAN; KIDNEY CANCER; LIPID RAFT; LUNG CANCER; MELANOMA; NASOPHARYNX CARCINOMA; NEUROBLASTOMA CELL; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPLEEN CANCER; THYROID CANCER; UROGENITAL TRACT CANCER; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR CELL CULTURE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; CALCIUM; CALCIUM CHANNELS; CHLORIDE CHANNELS; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; LINOLEIC ACIDS, CONJUGATED; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; NEOPLASMS; POTASSIUM CHANNELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84941241604     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.10.036     Document Type: Review

References (286)

1. L.J. Pike Lipid rafts: bringing order to chaos J. Lipid Res. 44 2003 655 667
2. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
3. G.R. Ravacci, M.M. Brentani, T. Tortelli Jr., R.S. Torrinhas, T. Saldanha, E.A. Torres, and D.L. Waitzberg Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression J. Nutr. Biochem. 24 2013 505 515
4. M.E. Irwin, K.L. Mueller, N. Bohin, Y. Ge, and J.L. Boerner Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib J. Cell. Physiol. 226 2011 2316 2328
5. P. Sanchez-Gonzalez, K. Jellali, and A. Villalobo Calmodulin-mediated regulation of the epidermal growth factor receptor FEBS J. 277 2010 327 342
6. A. Girault, J.P. Haelters, M. Potier-Cartereau, A. Chantome, P.A. Jaffres, P. Bougnoux, V. Joulin, and C. Vandier Targeting SKCa channels in cancer: potential new therapeutic approaches Curr. Med. Chem. 19 2012 697 713
7. L.A. Pardo, and W. Stuhmer The roles of K(+) channels in cancer Nat. Rev. Cancer 14 2014 39 48
8. N. Prevarskaya, R. Skryma, and Y. Shuba Calcium in tumour metastasis: new roles for known actors Nat. Rev. Cancer 11 2011 609 618
9. Z. Qu, W. Yao, R. Yao, X. Liu, K. Yu, and C. Hartzell The Ca(2 +)-activated Cl(-) channel, ANO1 (TMEM16A), is a double-edged sword in cell proliferation and tumorigenesis Cancer Med. 3 2014 453 461
10. N. Villalonga, J.C. Ferreres, J.M. Argiles, E. Condom, and A. Felipe Potassium channels are a new target field in anticancer drug design Recent Pat. Anticancer Drug Discov. 2 2007 212 223
11. M. Gueguinou, A. Chantome, G. Fromont, P. Bougnoux, C. Vandier, and M. Potier-Cartereau KCa and Ca channels: the complex thought Biochim. Biophys. Acta 1843 10 2014 2322 2333
12. H.L. Ong, and I.S. Ambudkar The dynamic complexity of the TRPC1 channelosome Channels (Austin) 5 2011 424 431
13. C. Dart Lipid microdomains and the regulation of ion channel function J. Physiol. 588 2010 3169 3178
14. A. Hryniewicz-Jankowska, K. Augoff, A. Biernatowska, J. Podkalicka, and A.F. Sikorski Membrane rafts as a novel target in cancer therapy Biochim. Biophys. Acta 1845 2014 155 165
15. G.P. Otto, and B.J. Nichols The roles of flotillin microdomains - endocytosis and beyond J. Cell Sci. 124 2011 3933 3940
16. R.G. Parton, and M.A. del Pozo Caveolae as plasma membrane sensors, protectors and organizers Nat. Rev. Mol. Cell Biol. 14 2013 98 112
17. S. Staubach, and F.G. Hanisch Lipid rafts: signaling and sorting platforms of cells and their roles in cancer Expert Rev. Proteomics 8 2011 263 277
18. D.A. Brown, and J.K. Rose Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface Cell 68 1992 533 544
19. D. Lingwood, and K. Simons Lipid rafts as a membrane-organizing principle Science 327 2010 46 50
20. J.S. Chen, K.T. Chen, C.W. Fan, C.L. Han, Y.J. Chen, J.S. Yu, Y.S. Chang, C.W. Chien, C.P. Wu, R.P. Hung, and E.C. Chan Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry FEBS J. 277 2010 3028 3038
21. M. Murata, J. Peranen, R. Schreiner, F. Wieland, T.V. Kurzchalia, and K. Simons VIP21/caveolin is a cholesterol-binding protein Proc. Natl. Acad. Sci. U. S. A. 92 1995 10339 10343
22. Q. Cai, L. Guo, H. Gao, and X.A. Li Caveolar fatty acids and acylation of caveolin-1 PLoS ONE 8 2013 e60884
23. S.K. Patra Dissecting lipid raft facilitated cell signaling pathways in cancer Biochim. Biophys. Acta 1785 2008 182 206
24. J.A. Crowell, V.E. Steele, and J.R. Fay Targeting the AKT protein kinase for cancer chemoprevention Mol. Cancer Ther. 6 2007 2139 2148
25. M.M. Hill, and B.A. Hemmings Inhibition of protein kinase B/Akt. Implications for cancer therapy Pharmacol. Ther. 93 2002 243 251
26. T.F. Franke PI3K/Akt: getting it right matters Oncogene 27 2008 6473 6488
27. Y.C. Li, M.J. Park, S.K. Ye, C.W. Kim, and Y.N. Kim Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents Am. J. Pathol. 168 2006 1107 1118 (quiz 1404-1105)
28. D.A. Brown Lipid rafts, detergent-resistant membranes, and raft targeting signals Physiology (Bethesda) 21 2006 430 439
29. R. Lasserre, X.J. Guo, F. Conchonaud, Y. Hamon, O. Hawchar, A.M. Bernard, S.M. Soudja, P.F. Lenne, H. Rigneault, D. Olive, G. Bismuth, J.A. Nunes, B. Payrastre, D. Marguet, and H.T. He Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation Nat. Chem. Biol. 4 2008 538 547
30. M.P. Wymann, and R. Schneiter Lipid signalling in disease Nat. Rev. Mol. Cell Biol. 9 2008 162 176
31. X. Gao, and J. Zhang Spatiotemporal analysis of differential Akt regulation in plasma membrane microdomains Mol. Biol. Cell 19 2008 4366 4373
32. G. Baillat, C. Siret, E. Delamarre, and J. Luis Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells Biochim. Biophys. Acta 1783 2008 2323 2331
33. L. Zhuang, J. Lin, M.L. Lu, K.R. Solomon, and M.R. Freeman Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells Cancer Res. 62 2002 2227 2231
34. 2 +/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth Carcinogenesis 33 2012 740 750
35. F. Guardiola-Serrano, A. Rossin, N. Cahuzac, K. Luckerath, I. Melzer, S. Mailfert, D. Marguet, M. Zornig, and A.O. Hueber Palmitoylation of human FasL modulates its cell death-inducing function Cell Death Dis. 1 2010 e88
36. C. Gajate, E. Del Canto-Janez, A.U. Acuna, F. Amat-Guerri, E. Geijo, A.M. Santos-Beneit, R.J. Veldman, and F. Mollinedo Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis J. Exp. Med. 200 2004 353 365
37. F. Mollinedo, and C. Gajate Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy Drug Resist. Updat. 9 2006 51 73
38. C. Gajate, and F. Mollinedo Lipid rafts and Fas/CD95 signaling in cancer chemotherapy Recent Pat. Anticancer Drug Discov. 6 2011 274 283
39. C. Gajate, and F. Mollinedo Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy J. Biol. Chem. 280 2005 11641 11647
40. N. Cahuzac, W. Baum, V. Kirkin, F. Conchonaud, L. Wawrezinieck, D. Marguet, O. Janssen, M. Zornig, and A.O. Hueber Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity Blood 107 2006 2384 2391
41. J.R. Muppidi, and R.M. Siegel Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death Nat. Immunol. 5 2004 182 189
42. F. Mollinedo, M. Fernandez, V. Hornillos, J. Delgado, F. Amat-Guerri, A.U. Acuna, T. Nieto-Miguel, J.A. Villa-Pulgarin, C. Gonzalez-Garcia, V. Cena, and C. Gajate Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria Cell Death Dis 2 2011 e158
43. D. Colin, E. Limagne, S. Jeanningros, A. Jacquel, G. Lizard, A. Athias, P. Gambert, A. Hichami, N. Latruffe, E. Solary, and D. Delmas Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells Cancer Prev. Res. (Phila) 4 2011 1095 1106
44. D. Delmas, C. Rebe, S. Lacour, R. Filomenko, A. Athias, P. Gambert, M. Cherkaoui-Malki, B. Jannin, L. Dubrez-Daloz, N. Latruffe, and E. Solary Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells J. Biol. Chem. 278 2003 41482 41490
45. S. Lacour, A. Hammann, S. Grazide, D. Lagadic-Gossmann, A. Athias, O. Sergent, G. Laurent, P. Gambert, E. Solary, and M.T. Dimanche-Boitrel Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells Cancer Res. 64 2004 3593 3598
46. S. DeMorrow, S. Glaser, H. Francis, J. Venter, B. Vaculin, S. Vaculin, and G. Alpini Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts J. Biol. Chem. 282 2007 13098 13113
47. J. Kwik, S. Boyle, D. Fooksman, L. Margolis, M.P. Sheetz, and M. Edidin Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin Proc. Natl. Acad. Sci. U. S. A. 100 2003 13964 13969
48. S. Oliferenko, K. Paiha, T. Harder, V. Gerke, C. Schwarzler, H. Schwarz, H. Beug, U. Gunthert, and L.A. Huber Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton J. Cell Biol. 146 1999 843 854
49. P. Gopalakrishna, S.K. Chaubey, P.S. Manogaran, and G. Pande Modulation of alpha5beta1 integrin functions by the phospholipid and cholesterol contents of cell membranes J. Cell. Biochem. 77 2000 517 528
50. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
51. P. Hubert Growth factors of the EGF family and their receptors Bull. Cancer 94 2007 F137 F145
52. T. Holbro, and N.E. Hynes ErbB receptors: directing key signaling networks throughout life Annu. Rev. Pharmacol. Toxicol. 44 2004 195 217
53. A.B. Singh, and R.C. Harris Autocrine, paracrine and juxtacrine signaling by EGFR ligands Cell. Signal. 17 2005 1183 1193
54. W. Cai, G. Niu, and X. Chen Multimodality imaging of the HER-kinase axis in cancer Eur. J. Nucl. Med. Mol. Imaging 35 2008 186 208
55. D.N. Amin, M.R. Campbell, and M.M. Moasser The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics Semin. Cell Dev. Biol. 21 2010 944 950
56. N.V. Sergina, and M.M. Moasser The HER family and cancer: emerging molecular mechanisms and therapeutic targets Trends Mol. Med. 13 2007 527 534
57. T. Holbro, G. Civenni, and N.E. Hynes The ErbB receptors and their role in cancer progression Exp. Cell Res. 284 2003 99 110
58. J. Baselga, and C.L. Arteaga Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J. Clin. Oncol. 23 2005 2445 2459
59. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat. Rev. Cancer 5 2005 341 354
60. A. Gschwind, O.M. Fischer, and A. Ullrich The discovery of receptor tyrosine kinases: targets for cancer therapy Nat. Rev. Cancer 4 2004 361 370
61. B.A. Gusterson, and K.D. Hunter Should we be surprised at the paucity of response to EGFR inhibitors? Lancet Oncol. 10 2009 522 527
62. C. Arteaga Targeting HER1/EGFR: a molecular approach to cancer therapy Semin. Oncol. 30 2003 3 14
63. M. Azuma, K.D. Danenberg, S. Iqbal, A. El-Khoueiry, W. Zhang, D. Yang, W. Koizumi, K. Saigenji, P.V. Danenberg, and H.J. Lenz Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer Clin. Colorectal Cancer 6 2006 214 218
64. K.L. Spindler, D.A. Olsen, J.N. Nielsen, I. Brandslund, H.S. Poulsen, M. Villingshoj, and A. Jakobsen Lack of the type III epidermal growth factor receptor mutation in colorectal cancer Anticancer Res. 26 2006 4889 4893
65. J. Schlessinger Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110 2002 669 672
66. J.A. Krall, E.M. Beyer, and G. MacBeath High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways PLoS ONE 6 2011 e15945
67. F. Ozcan, P. Klein, M.A. Lemmon, I. Lax, and J. Schlessinger On the nature of low- and high-affinity EGF receptors on living cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 5735 5740
68. G. Liccardi, J.A. Hartley, and D. Hochhauser EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment Cancer Res. 71 2011 1103 1114
69. H.W. Lo Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications Discov. Med. 10 2010 44 51
70. H.W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.C. Hung Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res. 65 2005 338 348
71. J. Neumann, L. Wehweck, S. Maatz, J. Engel, T. Kirchner, and A. Jung Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis Virchows Arch. 463 2013 509 523
72. S. Morgan, and J.R. Grandis ErbB receptors in the biology and pathology of the aerodigestive tract Exp. Cell Res. 315 2009 572 582
73. M.A. Owens, B.C. Horten, and M.M. Da Silva HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues Clin. Breast Cancer 5 2004 63 69
74. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
75. Y. Song, J. Huang, and J.W. Wang Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma Chin. J. Cancer 29 2010 76 81
76. Y. Yonemura, I. Ninomiya, A. Yamaguchi, S. Fushida, H. Kimura, S. Ohoyama, I. Miyazaki, Y. Endou, M. Tanaka, and T. Sasaki Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer Cancer Res. 51 1991 1034 1038
77. A. Berchuck, A. Kamel, R. Whitaker, B. Kerns, G. Olt, R. Kinney, J.T. Soper, R. Dodge, D.L. Clarke-Pearson, P. Marks, and et al. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer Cancer Res. 50 1990 4087 4091
78. N. Buza, D.M. Roque, and A.D. Santin HER2/neu in endometrial cancer: a promising therapeutic target with diagnostic challenges Arch. Pathol. Lab. Med. 138 2014 343 350
79. A. Goldhirsch, W.C. Wood, R.D. Gelber, A.S. Coates, B. Thurlimann, and H.J. Senn Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann. Oncol. 18 2007 1133 1144
80. A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, R.J. Cote, M. Dowsett, P.L. Fitzgibbons, W.M. Hanna, A. Langer, L.M. McShane, S. Paik, M.D. Pegram, E.A. Perez, M.F. Press, A. Rhodes, C. Sturgeon, S.E. Taube, R. Tubbs, G.H. Vance, M. van de Vijver, T.M. Wheeler, and D.F. Hayes American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J. Clin. Oncol. 25 2007 118 145
81. E.H. Romond, E.A. Perez, J. Bryant, V.J. Suman, C.E. Geyer Jr., N.E. Davidson, E. Tan-Chiu, S. Martino, S. Paik, P.A. Kaufman, S.M. Swain, T.M. Pisansky, L. Fehrenbacher, L.A. Kutteh, V.G. Vogel, D.W. Visscher, G. Yothers, R.B. Jenkins, A.M. Brown, S.R. Dakhil, E.P. Mamounas, W.L. Lingle, P.M. Klein, J.N. Ingle, and N. Wolmark Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N. Engl. J. Med. 353 2005 1673 1684
82. I. Smith, M. Procter, R.D. Gelber, S. Guillaume, A. Feyereislova, M. Dowsett, A. Goldhirsch, M. Untch, G. Mariani, J. Baselga, M. Kaufmann, D. Cameron, R. Bell, J. Bergh, R. Coleman, A. Wardley, N. Harbeck, R.I. Lopez, P. Mallmann, K. Gelmon, N. Wilcken, E. Wist, P. Sanchez Rovira, and M.J. Piccart-Gebhart 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial Lancet 369 2007 29 36
83. M. De Tursi, and C. Carella Lapatinib in second-line treatment for metastatic breast cancer: rapid clinical benefit and long-term response Tumori 99 2013 261e 263e
84. S. Tolaney New HER2-positive targeting agents in clinical practice Curr. Oncol. Rep. 16 2014 359
85. P.M. Guy, J.V. Platko, L.C. Cantley, R.A. Cerione, and K.L. Carraway III Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity Proc. Natl. Acad. Sci. U. S. A. 91 1994 8132 8136
86. T.D. Prickett, N.S. Agrawal, X. Wei, K.E. Yates, J.C. Lin, J.R. Wunderlich, J.C. Cronin, P. Cruz, S.A. Rosenberg, and Y. Samuels Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4 Nat. Genet. 41 2009 1127 1132
87. W. Xia, Y.K. Lau, H.Z. Zhang, F.Y. Xiao, D.A. Johnston, A.R. Liu, L. Li, R.L. Katz, and M.C. Hung Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members Clin. Cancer Res. 5 1999 4164 4174
88. M. Tateishi, T. Ishida, S. Kohdono, M. Hamatake, Y. Fukuyama, and K. Sugimachi Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma Surg. Oncol. 3 1994 109 113
89. J.R. Molina, and A.A. Adjei The Ras/Raf/MAPK pathway J. Thorac. Oncol. 1 2006 7 9
90. J.A. Engelman Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat. Rev. Cancer 9 2009 550 562
91. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv. Cancer Res. 94 2005 29 86
92. B.H. Jiang, and L.Z. Liu PI3K/PTEN signaling in angiogenesis and tumorigenesis Adv. Cancer Res. 102 2009 19 65
93. M.S. Song, L. Salmena, and P.P. Pandolfi The functions and regulation of the PTEN tumour suppressor Nat. Rev. Mol. Cell Biol. 13 2012 283 296
94. S. Zhang, and D. Yu PI(3)king apart PTEN's role in cancer Clin. Cancer Res. 16 2010 4325 4330
95. W.H. Moolenaar, R.J. Aerts, L.G. Tertoolen, and S.W. de Laat The epidermal growth factor-induced calcium signal in A431 cells J. Biol. Chem. 261 1986 279 284
96. 2 + in A431 and Swiss 3T3 cells by a dual mechanism. Redistribution from intracellular stores and stimulated influx Exp. Cell Res. 170 1987 175 185
97. E.M. Brown, G. Gamba, D. Riccardi, M. Lombardi, R. Butters, O. Kifor, A. Sun, M.A. Hediger, J. Lytton, and S.C. Hebert Cloning and characterization of an extracellular Ca(2 +)-sensing receptor from bovine parathyroid Nature 366 1993 575 580
98. S.C. Brennan, U. Thiem, S. Roth, A. Aggarwal, I. Fetahu, S. Tennakoon, A.R. Gomes, M.L. Brandi, F. Bruggeman, R. Mentaverri, D. Riccardi, and E. Kallay Calcium sensing receptor signalling in physiology and cancer Biochim. Biophys. Acta 1833 2013 1732 1744
99. E.M. Brown, and R.J. MacLeod Extracellular calcium sensing and extracellular calcium signaling Physiol. Rev. 81 2001 239 297
100. S.A. Hobson, S.E. McNeil, F. Lee, and K.D. Rodland Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells Exp. Cell Res. 258 2000 1 11
101. R.J. MacLeod, S. Yano, N. Chattopadhyay, and E.M. Brown Extracellular calcium-sensing receptor transactivates the epidermal growth factor receptor by a triple-membrane-spanning signaling mechanism Biochem. Biophys. Res. Commun. 320 2004 455 460
102. S. Yano, R.J. Macleod, N. Chattopadhyay, J. Tfelt-Hansen, O. Kifor, R.R. Butters, and E.M. Brown Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation Bone 35 2004 664 672
103. Y. El Hiani, A. Ahidouch, V. Lehen'kyi, F. Hague, F. Gouilleux, R. Mentaverri, S. Kamel, K. Lassoued, G. Brule, and H. Ouadid-Ahidouch Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation Cell. Physiol. Biochem. 23 2009 335 346
104. Y. El Hiani, V. Lehen'kyi, H. Ouadid-Ahidouch, and A. Ahidouch Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways Arch. Biochem. Biophys. 486 2009 58 63
105. A. Benguria, J. Martin-Nieto, G. Benaim, and A. Villalobo Regulatory interaction between calmodulin and the epidermal growth factor receptor Ann. N. Y. Acad. Sci. 766 1995 472 476
106. H. Li, and A. Villalobo Evidence for the direct interaction between calmodulin and the human epidermal growth factor receptor Biochem. J. 362 2002 499 505
107. J. Martin-Nieto, and A. Villalobo The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site Biochemistry 37 1998 227 236
108. A. Villalobo, I. Garcia-Palmero, S.R. Stateva, and K. Jellali Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy J. Pharm. Pharm. Sci. 16 2013 177 189
109. M. Red Brewer, S.H. Choi, D. Alvarado, K. Moravcevic, A. Pozzi, M.A. Lemmon, and G. Carpenter The juxtamembrane region of the EGF receptor functions as an activation domain Mol. Cell 34 2009 641 651
110. P. Sengupta, E. Bosis, E. Nachliel, M. Gutman, S.O. Smith, G. Mihalyne, I. Zaitseva, and S. McLaughlin EGFR juxtamembrane domain, membranes, and calmodulin: kinetics of their interaction Biophys. J. 96 2009 4887 4895
111. H. Li, S. Panina, A. Kaur, M.J. Ruano, P. Sanchez-Gonzalez, J.M. la Cour, A. Stephan, U.H. Olesen, M.W. Berchtold, and A. Villalobo Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin J. Biol. Chem. 287 2012 3273 3281
112. C.M. Coticchia, C.M. Revankar, T.B. Deb, R.B. Dickson, and M.D. Johnson Calmodulin modulates Akt activity in human breast cancer cell lines Breast Cancer Res. Treat. 115 2009 545 560
113. F.S. Wouters, and P.I. Bastiaens Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells Curr. Biol. 9 1999 1127 1130
114. C. Mineo, G.L. James, E.J. Smart, and R.G. Anderson Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane J. Biol. Chem. 271 1996 11930 11935
115. J. Couet, M. Sargiacomo, and M.P. Lisanti Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities J. Biol. Chem. 272 1997 30429 30438
116. J.A. Engelman, C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D.S. Kohtz, and M.P. Lisanti Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain FEBS Lett. 428 1998 205 211
117. A. Abulrob, S. Giuseppin, M.F. Andrade, A. McDermid, M. Moreno, and D. Stanimirovic Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae Oncogene 23 2004 6967 6979
118. T. Ringerike, F.D. Blystad, F.O. Levy, I.H. Madshus, and E. Stang Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae J. Cell Sci. 115 2002 1331 1340
119. K. Roepstorff, P. Thomsen, K. Sandvig, and B. van Deurs Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding J. Biol. Chem. 277 2002 18954 18960
120. M. Amaddii, M. Meister, A. Banning, A. Tomasovic, J. Mooz, K. Rajalingam, and R. Tikkanen Flotillin-1/reggie-2 protein plays dual role in activation of receptor-tyrosine kinase/mitogen-activated protein kinase signaling J. Biol. Chem. 287 2012 7265 7278
121. P. Liu, Y. Ying, Y.G. Ko, and R.G. Anderson Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae J. Biol. Chem. 271 1996 10299 10303
122. E. Sottocornola, R. Misasi, V. Mattei, L. Ciarlo, R. Gradini, T. Garofalo, B. Berra, I. Colombo, and M. Sorice Role of gangliosides in the association of ErbB2 with lipid rafts in mammary epithelial HC11 cells FEBS J. 273 2006 1821 1830
123. J. Couet, S. Li, T. Okamoto, T. Ikezu, and M.P. Lisanti Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins J. Biol. Chem. 272 1997 6525 6533
124. C. Mineo, G.N. Gill, and R.G. Anderson Regulated migration of epidermal growth factor receptor from caveolae J. Biol. Chem. 274 1999 30636 30643
125. N. Moghal, and P.W. Sternberg Multiple positive and negative regulators of signaling by the EGF-receptor Curr. Opin. Cell Biol. 11 1999 190 196
126. N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
127. K.A. Lund, C.S. Lazar, W.S. Chen, B.J. Walsh, J.B. Welsh, J.J. Herbst, G.M. Walton, M.G. Rosenfeld, G.N. Gill, and H.S. Wiley Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation J. Biol. Chem. 265 1990 20517 20523
128. P. Burke, K. Schooler, and H.S. Wiley Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking Mol. Biol. Cell 12 2001 1897 1910
129. M.P. Oksvold, E. Skarpen, L. Wierod, R.E. Paulsen, and H.S. Huitfeldt Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF Eur. J. Cell Biol. 80 2001 285 294
130. X. Chen, and M.D. Resh Activation of mitogen-activated protein kinase by membrane-targeted Raf chimeras is independent of raft localization J. Biol. Chem. 276 2001 34617 34623
131. S. Lambert, D. Vind-Kezunovic, S. Karvinen, and R. Gniadecki Ligand-independent activation of the EGFR by lipid raft disruption J. Investig. Dermatol. 126 2006 954 962
132. X. Chen, and M.D. Resh Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor J. Biol. Chem. 277 2002 49631 49637
133. T. Furuchi, and R.G. Anderson Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK) J. Biol. Chem. 273 1998 21099 21104
134. M.E. Irwin, N. Bohin, and J.L. Boerner Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells Cancer Biol. Ther. 12 2011 718 726
135. V.C. Bomben, K.L. Turner, T.T. Barclay, and H. Sontheimer Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas J. Cell. Physiol. 226 2011 1879 1888
136. D. Pigozzi, T. Ducret, N. Tajeddine, J.L. Gala, B. Tombal, and P. Gailly Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line Cell Calcium 39 2006 401 415
137. M. Monet, D. Gkika, V. Lehen'kyi, A. Pourtier, F. Vanden Abeele, G. Bidaux, V. Juvin, F. Rassendren, S. Humez, and N. Prevarsakaya Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation Biochim. Biophys. Acta 1793 2009 528 539
138. M. Monet, V. Lehen'kyi, F. Gackiere, V. Firlej, M. Vandenberghe, M. Roudbaraki, D. Gkika, A. Pourtier, G. Bidaux, C. Slomianny, P. Delcourt, F. Rassendren, J.P. Bergerat, J. Ceraline, F. Cabon, S. Humez, and N. Prevarskaya Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance Cancer Res. 70 2010 1225 1235
139. X. Zeng, S.C. Sikka, L. Huang, C. Sun, C. Xu, D. Jia, A.B. Abdel-Mageed, J.E. Pottle, J.T. Taylor, and M. Li Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation Prostate Cancer Prostatic Dis. 13 2010 195 201
140. I. Dhennin-Duthille, M. Gautier, M. Faouzi, A. Guilbert, M. Brevet, D. Vaudry, A. Ahidouch, H. Sevestre, and H. Ouadid-Ahidouch High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters Cell. Physiol. Biochem. 28 2011 813 822
141. A. Guilbert, M. Gautier, I. Dhennin-Duthille, P. Rybarczyk, J. Sahni, H. Sevestre, A.M. Scharenberg, and H. Ouadid-Ahidouch Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain Eur. J. Cancer 49 2011 3694 3707
142. A. Guilbert, M. Gautier, I. Dhennin-Duthille, N. Haren, H. Sevestre, and H. Ouadid-Ahidouch Evidence that TRPM7 is required for breast cancer cell proliferation Am. J. Physiol. Cell Physiol. 297 2009 C493 C502
143. K.A. Bolanz, M.A. Hediger, and C.P. Landowski The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther. 7 2008 271 279
144. W. Dai, Y. Bai, L. Hebda, X. Zhong, J. Liu, J. Kao, and C. Duan Calcium deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates abnormal epithelial cell proliferation Cell Death Differ. 21 2014 568 581
145. V. Lehen'kyi, M. Flourakis, R. Skryma, and N. Prevarskaya TRPV6 channel controls prostate cancer cell proliferation via Ca(2 +)/NFAT-dependent pathways Oncogene 26 2007 7380 7385
146. Y.F. Chen, W.T. Chiu, Y.T. Chen, P.Y. Lin, H.J. Huang, C.Y. Chou, H.C. Chang, M.J. Tang, and M.R. Shen Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis Proc. Natl. Acad. Sci. U. S. A. 108 2011 15225 15230
147. R.K. Motiani, X. Zhang, K.E. Harmon, R.S. Keller, K. Matrougui, J.A. Bennett, and M. Trebak Orai3 is an estrogen receptor alpha-regulated Ca(2)(+) channel that promotes tumorigenesis FASEB J. 27 2013 63 75
148. S. Yang, J.J. Zhang, and X.Y. Huang Orai1 and STIM1 are critical for breast tumor cell migration and metastasis Cancer Cell 15 2009 124 134
149. M. Abdel-Ghany, H.C. Cheng, R.C. Elble, and B.U. Pauli Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth J. Biol. Chem. 277 2002 34391 34400
150. W. Liu, M. Lu, B. Liu, Y. Huang, and K. Wang Inhibition of Ca(2 +)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma Cancer Lett. 326 2012 41 51
151. C. Ayoub, C. Wasylyk, Y. Li, E. Thomas, L. Marisa, A. Robe, M. Roux, J. Abecassis, A. de Reynies, and B. Wasylyk ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines Br. J. Cancer 103 2010 715 726
152. I. Ubby, E. Bussani, A. Colonna, G. Stacul, M. Locatelli, P. Scudieri, L. Galietta, and F. Pagani TMEM16A alternative splicing coordination in breast cancer Mol. Cancer 12 2013 75
153. A. Britschgi, A. Bill, H. Brinkhaus, C. Rothwell, I. Clay, S. Duss, M. Rebhan, P. Raman, C.T. Guy, K. Wetzel, E. George, M.O. Popa, S. Lilley, H. Choudhury, M. Gosling, L. Wang, S. Fitzgerald, J. Borawski, J. Baffoe, M. Labow, L.A. Gaither, and M. Bentires-Alj Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling Proc. Natl. Acad. Sci. U. S. A. 110 2013 E1026 E1034
154. U. Duvvuri, D.J. Shiwarski, D. Xiao, C. Bertrand, X. Huang, R.S. Edinger, J.R. Rock, B.D. Harfe, B.J. Henson, K. Kunzelmann, R. Schreiber, R.S. Seethala, A.M. Egloff, X. Chen, V.W. Lui, J.R. Grandis, and S.M. Gollin TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression Cancer Res. 72 2012 3270 3281
155. A. Chantome, M. Potier-Cartereau, L. Clarysse, G. Fromont, S. Marionneau-Lambot, M. Gueguinou, J.C. Pages, C. Collin, T. Oullier, A. Girault, F. Arbion, J.P. Haelters, P.A. Jaffres, M. Pinault, P. Besson, V. Joulin, P. Bougnoux, and C. Vandier Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases Cancer Res. 73 2013 4852 4861
156. + channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry Oncogene 28 2009 1792 1806
157. M. Hammadi, V. Chopin, F. Matifat, I. Dhennin-Duthille, M. Chasseraud, H. Sevestre, and H. Ouadid-Ahidouch Human ether a-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry J. Cell. Physiol. 227 2012 3837 3846
158. V.A. Cuddapah, K.L. Turner, and H. Sontheimer Calcium entry via TRPC1 channels activates chloride currents in human glioma cells Cell Calcium 53 2013 187 194
159. R.S. Lam, A.R. Shaw, and M. Duszyk Membrane cholesterol content modulates activation of BK channels in colonic epithelia Biochim. Biophys. Acta 1667 2004 241 248
160. + channels in vascular endothelial cells J. Biol. Chem. 280 2005 11656 11664
161. A.K. Weaver, M.L. Olsen, M.B. McFerrin, and H. Sontheimer BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca(2 +)](i) to ion channel activation J. Biol. Chem. 282 2007 31558 31568
162. A.M. Brainard, V.P. Korovkina, and S.K. England Disruption of the maxi-K-caveolin-1 interaction alters current expression in human myometrial cells Reprod. Biol. Endocrinol. 7 2009 131
163. +-ATPase in human melanoma IGR39 cells J. Biol. Chem. 286 2011 5624 5638
164. 2 + channels and their clustering to regulate membrane excitability in vascular myocytes J. Biol. Chem. 288 2013 36750 36761
165. A. Feher, I. Rutkai, T. Beleznai, Z. Ungvari, A. Csiszar, I. Edes, and Z. Bagi Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity Cardiovasc. Res. 87 2010 732 739
166. A. Mound, L. Rodat-Despoix, S. Bougarn, H. Ouadid-Ahidouch, and F. Matifat Molecular interaction and functional coupling between type 3 inositol 1,4,5-trisphosphate receptor and BKCa channel stimulate breast cancer cell proliferation Eur. J. Cancer 49 2013 3738 3751
167. G. Gessner, K. Schonherr, M. Soom, A. Hansel, M. Asim, A. Baniahmad, C. Derst, T. Hoshi, and S.H. Heinemann BKCa channels activating at resting potential without calcium in LNCaP prostate cancer cells J. Membr. Biol. 208 2005 229 240
168. J. Yan, and R.W. Aldrich BK potassium channel modulation by leucine-rich repeat-containing proteins Proc. Natl. Acad. Sci. U. S. A. 109 2012 7917 7922
169. A.H. Weston, M. Absi, D.T. Ward, J. Ohanian, R.H. Dodd, P. Dauban, C. Petrel, M. Ruat, and G. Edwards Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231 Circ. Res. 97 2005 391 398
170. M. Absi, M.P. Burnham, A.H. Weston, E. Harno, M. Rogers, and G. Edwards Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains Br. J. Pharmacol. 151 2007 332 340
171. + channel, KCa2.3 PLoS ONE 7 2012 e44150
172. L. Clarysse, M. Gueguinou, M. Potier-Cartereau, G. Vandecasteele, P. Bougnoux, S. Chevalier, A. Chantome, and C. Vandier cAMP-PKA inhibition of SK3 channel reduced both Ca entry and cancer cell migration by regulation of SK3-Orai1 complex Pflugers Arch. 466 10 2014 1921 1932
173. 2 +-activated IK1 channels associate with lipid rafts upon cell swelling and mediate volume recovery J. Biol. Chem. 282 2007 8984 8993
174. S.L. Brownlow, and S.O. Sage Transient receptor potential protein subunit assembly and membrane distribution in human platelets Thromb. Haemost. 94 2005 839 845
175. T.P. Lockwich, X. Liu, B.B. Singh, J. Jadlowiec, S. Weiland, and I.S. Ambudkar Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains J. Biol. Chem. 275 2000 11934 11942
176. T. Murata, M.I. Lin, R.V. Stan, P.M. Bauer, J. Yu, and W.C. Sessa Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells J. Biol. Chem. 282 2007 16631 16643
177. 2 + entry SOCE J. Biol. Chem. 283 2008 17333 17340
178. A. Berthier, S. Lemaire-Ewing, C. Prunet, S. Monier, A. Athias, G. Bessede, J.P. Pais de Barros, A. Laubriet, P. Gambert, G. Lizard, and D. Neel Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis Cell Death Differ. 11 2004 897 905
179. A. Sampieri, A. Zepeda, C. Saldaña, A. Salgado, and L. Vaca STIM1 converts TRPC1 from a receptor-operated to a store-operated channel: moving TRPC1 in and out of lipid rafts Cell Calcium 44 2008 479 491
180. 2 + entry Proc. Natl. Acad. Sci. U. S. A. 106 2009 3202 3206
181. 2 + influx channels by regulating plasma membrane localization of TRPC1 J. Biol. Chem. 278 2003 27208 27215
182. 2 + entry Curr. Top. Membr. 71 2013 149 179
183. B. Pani, X. Liu, S. Bollimuntha, K.T. Cheng, I.R. Niesman, C. Zheng, V.R. Achen, H.H. Patel, I.S. Ambudkar, and B.B. Singh Impairment of TRPC1-STIM1 channel assembly and AQP5 translocation compromise agonist-stimulated fluid secretion in mice lacking caveolin1 J. Cell Sci. 126 2013 667 675
184. B. Pani, H.L. Ong, S.C. Brazer, X. Liu, K. Rauser, B.B. Singh, and I.S. Ambudkar Activation of TRPC1 by STIM1 in ER-PM microdomains involves release of the channel from its scaffold caveolin-1 Proc. Natl. Acad. Sci. U. S. A. 106 2009 20087 20092
185. 2 + entry in endothelial cells Am. J. Physiol. Cell Physiol. 296 2009 C403 C413
186. V.B. Pena, I.C. Bonini, S.S. Antollini, T. Kobayashi, and F.J. Barrantes alpha 7-type acetylcholine receptor localization and its modulation by nicotine and cholesterol in vascular endothelial cells J. Cell. Biochem. 112 2011 3276 3288
187. V. Zarayskiy, F. Monje, K. Peter, P. Csutora, B.I. Khodorov, and V.M. Bolotina Store-operated Orai1 and IP3 receptor-operated TRPC1 channel Channels (Austin) 1 2007 246 252
188. H. Sontheimer An unexpected role for ion channels in brain tumor metastasis Exp. Biol. Med. (Maywood) 233 2008 779 791
189. H.F. Turk, and R.S. Chapkin Membrane lipid raft organization is uniquely modified by n- 3 polyunsaturated fatty acids Prostaglandins Leukot. Essent. Fatty Acids 88 2013 43 47
190. R.S. Chapkin, N. Wang, Y.Y. Fan, J.R. Lupton, and I.A. Prior Docosahexaenoic acid alters the size and distribution of cell surface microdomains Biochim. Biophys. Acta 1778 2008 466 471
191. + T cells by affecting lipid raft formation J. Immunol. 181 2008 6236 6243
192. Y.Y. Fan, L.H. Ly, R. Barhoumi, D.N. McMurray, and R.S. Chapkin Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production J. Immunol. 173 2004 6151 6160
193. Y.Y. Fan, D.N. McMurray, L.H. Ly, and R.S. Chapkin Dietary (n - 3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts J. Nutr. 133 2003 1913 1920
194. D.W. Ma, J. Seo, L.A. Davidson, E.S. Callaway, Y.Y. Fan, J.R. Lupton, and R.S. Chapkin n - 3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon FASEB J. 18 2004 1040 1042
195. P.D. Schley, D.N. Brindley, and C.J. Field (n - 3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells J. Nutr. 137 2007 548 553
196. K.R. Rogers, K.D. Kikawa, M. Mouradian, K. Hernandez, K.M. McKinnon, S.M. Ahwah, and R.S. Pardini Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association Carcinogenesis 31 2010 1523 1530
197. H.F. Turk, R. Barhoumi, and R.S. Chapkin Alteration of EGFR spatiotemporal dynamics suppresses signal transduction PLoS ONE 7 2012 e39682
198. S. Shin, K. Jing, S. Jeong, N. Kim, K.S. Song, J.Y. Heo, J.H. Park, K.S. Seo, J. Han, J.I. Park, G.R. Kweon, S.K. Park, T. Wu, B.D. Hwang, and K. Lim The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53 Biomed. Res. Int. 2013 2013 568671
199. Z. Gu, J. Wu, S. Wang, J. Suburu, H. Chen, M.J. Thomas, L. Shi, I.J. Edwards, I.M. Berquin, and Y.Q. Chen Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells Carcinogenesis 34 2013 1968 1975
200. S.B. Sato, J. Park, J. Kawamoto, S. Sato, and T. Kurihara Inhibition of constitutive Akt (PKB) phosphorylation by docosahexaenoic acid in the human breast cancer cell line MDA-MB-453 Biochim. Biophys. Acta 1831 2013 306 313
201. P.S. Huot, B. Sarkar, and D.W. Ma Conjugated linoleic acid alters caveolae phospholipid fatty acid composition and decreases caveolin-1 expression in MCF-7 breast cancer cells Nutr. Res. 30 2010 179 185
202. M. Jowett The phosphatide and cholesterol contents of normal and malignant human tissues Biochem. J. 25 1931 1991 1998
203. M.F. Mulas, C. Abete, D. Pulisci, A. Pani, B. Massidda, S. Dessi, and A. Mandas Cholesterol esters as growth regulators of lymphocytic leukaemia cells Cell Prolif. 44 2011 360 371
204. M.R. Freeman, and K.R. Solomon Cholesterol and benign prostate disease Differentiation 82 2011 244 252
205. M.R. Tosi, and V. Tugnoli Cholesteryl esters in malignancy Clin. Chim. Acta 359 2005 27 45
206. H.A. Drabkin, and R.M. Gemmill Cholesterol and the development of clear-cell renal carcinoma Curr. Opin. Pharmacol. 12 2012 742 750
207. M.R. Freeman, D. Di Vizio, and K.R. Solomon The Rafts of the Medusa: cholesterol targeting in cancer therapy Oncogene 29 2010 3745 3747
208. K. Hac-Wydro, P. Dynarowicz-Latka, P. Wydro, and K. Bak Edelfosine disturbs the sphingomyelin-cholesterol model membrane system in a cholesterol-dependent way - the Langmuir monolayer study Colloids Surf. B: Biointerfaces 88 2011 635 640
209. A. Ausili, A. Torrecillas, F.J. Aranda, F. Mollinedo, C. Gajate, S. Corbalan-Garcia, A. de Godos, and J.C. Gomez-Fernandez Edelfosine is incorporated into rafts and alters their organization J. Phys. Chem. B 112 2008 11643 11654
210. C. Gajate, and F. Mollinedo Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts Blood 109 2007 711 719
211. L. Ciarlo, V. Manganelli, T. Garofalo, P. Matarrese, A. Tinari, R. Misasi, W. Malorni, and M. Sorice Association of fission proteins with mitochondrial raft-like domains Cell Death Differ. 17 2010 1047 1058
212. T. Garofalo, A.M. Giammarioli, R. Misasi, A. Tinari, V. Manganelli, L. Gambardella, A. Pavan, W. Malorni, and M. Sorice Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells Cell Death Differ. 12 2005 1378 1389
213. M. Sorice, P. Matarrese, A. Tinari, A.M. Giammarioli, T. Garofalo, V. Manganelli, L. Ciarlo, L. Gambardella, G. Maccari, M. Botta, R. Misasi, and W. Malorni Raft component GD3 associates with tubulin following CD95/Fas ligation FASEB J. 23 2009 3298 3308
214. I. Annunziata, and A. d'Azzo Interorganellar membrane microdomains: dynamic platforms in the control of calcium signaling and apoptosis Cells 2 2013 574 590
215. R. Sano, I. Annunziata, A. Patterson, S. Moshiach, E. Gomero, J. Opferman, M. Forte, and A. d'Azzo GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2 +)-dependent mitochondrial apoptosis Mol. Cell 36 2009 500 511
216. M. Potier, A. Chantome, V. Joulin, A. Girault, S. Roger, P. Besson, M.L. Jourdan, J.Y. LeGuennec, P. Bougnoux, and C. Vandier The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine Br. J. Pharmacol. 162 2011 464 479
217. G.A. Ruiter, S.F. Zerp, H. Bartelink, W.J. van Blitterswijk, and M. Verheij Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway Anticancer Drugs 14 2003 167 173
218. S.R. Vink, S. Lagerwerf, E. Mesman, J.H. Schellens, A.C. Begg, W.J. van Blitterswijk, and M. Verheij Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts Clin. Cancer Res. 12 2006 1615 1622
219. M.P. Carrasco, J.M. Jimenez-Lopez, P. Rios-Marco, J.L. Segovia, and C. Marco Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues Br. J. Pharmacol. 160 2010 355 366
220. M.W. Pedersen, M. Meltorn, L. Damstrup, and H.S. Poulsen The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy Ann. Oncol. 12 2001 745 760
221. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska, D.N. Louis, D.C. Christiani, J. Settleman, and D.A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
222. D.A. Eberhard, B.E. Johnson, L.C. Amler, A.D. Goddard, S.L. Heldens, R.S. Herbst, W.L. Ince, P.A. Janne, T. Januario, D.H. Johnson, P. Klein, V.A. Miller, M.A. Ostland, D.A. Ramies, D. Sebisanovic, J.A. Stinson, Y.R. Zhang, S. Seshagiri, and K.J. Hillan Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib J. Clin. Oncol. 23 2005 5900 5909
223. E. Massarelli, F.M. Johnson, H.S. Erickson, I.I. Wistuba, and V. Papadimitrakopoulou Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance Lung Cancer 80 2013 235 241
224. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, and M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
225. S.V. Sharma, D.W. Bell, J. Settleman, and D.A. Haber Epidermal growth factor receptor mutations in lung cancer Nat. Rev. Cancer 7 2007 169 181
226. K. Iida, K. Nakayama, M.T. Rahman, M. Rahman, M. Ishikawa, A. Katagiri, S. Yeasmin, Y. Otsuki, H. Kobayashi, S. Nakayama, and K. Miyazaki EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target Br. J. Cancer 105 2011 420 427
227. S. Boeck, A. Jung, R.P. Laubender, J. Neumann, R. Egg, C. Goritschan, U. Vehling-Kaiser, C. Winkelmann, L. Fischer von Weikersthal, M.R. Clemens, T.C. Gauler, A. Marten, S. Klein, G. Kojouharoff, M. Barner, M. Geissler, T.F. Greten, U. Mansmann, T. Kirchner, and V. Heinemann EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104 Br. J. Cancer 108 2013 469 476
228. S. Kalyankrishna, and J.R. Grandis Epidermal growth factor receptor biology in head and neck cancer J. Clin. Oncol. 24 2006 2666 2672
229. J.F. Hechtman, and A.D. Polydorides HER2/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications Arch. Pathol. Lab. Med. 136 2012 691 697
230. L. Landi, and F. Cappuzzo HER2 and lung cancer Expert. Rev. Anticancer. Ther. 13 2013 1219 1228
231. R. Bose, S.M. Kavuri, A.C. Searleman, W. Shen, D. Shen, D.C. Koboldt, J. Monsey, N. Goel, A.B. Aronson, S. Li, C.X. Ma, L. Ding, E.R. Mardis, and M.J. Ellis Activating HER2 mutations in HER2 gene amplification negative breast cancer Cancer Discov. 3 2013 224 237
232. E.G. Jeong, Y.H. Soung, J.W. Lee, S.H. Lee, S.W. Nam, J.Y. Lee, N.J. Yoo, and S.H. Lee ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas Int. J. Cancer 119 2006 2986 2987
233. C. Lau, K.J. Killian, Y. Samuels, and U. Rudloff ERBB4 mutation analysis: emerging molecular target for melanoma treatment Methods Mol. Biol. 1102 2014 461 480
234. Y.H. Soung, J.W. Lee, S.Y. Kim, Y.P. Wang, K.H. Jo, S.W. Moon, W.S. Park, S.W. Nam, J.Y. Lee, N.J. Yoo, and S.H. Lee Somatic mutations of the ERBB4 kinase domain in human cancers Int. J. Cancer 118 2006 1426 1429
235. Y.T. Gu, L.J. Qin, X. Qin, and F. Xu The molecular mechanism of dexamethasone-mediated effect on the blood-brain tumor barrier permeability in a rat brain tumor model Neurosci. Lett. 452 2009 114 118
236. J. Hu, X. Yuan, M.K. Ko, D. Yin, M.R. Sacapano, X. Wang, B.M. Konda, A. Espinoza, K. Prosolovich, J.M. Ong, D. Irvin, and K.L. Black Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model Mol. Cancer 6 2007 22
237. D. Liu, C. Lu, R. Wan, W.W. Auyeung, and M.P. Mattson Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release J. Cereb. Blood Flow Metab. 22 2002 431 443
238. C.B. Ransom, X. Liu, and H. Sontheimer BK channels in human glioma cells have enhanced calcium sensitivity Glia 38 2002 281 291
239. A.K. Weaver, X. Liu, and H. Sontheimer Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells J. Neurosci. Res. 78 2004 224 234
240. A. Chantome, A. Girault, M. Potier, C. Collin, P. Vaudin, J.C. Pages, C. Vandier, and V. Joulin KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility Exp. Cell Res. 315 2009 3620 3630
241. M. Potier, T.A. Tran, A. Chantome, A. Girault, V. Joulin, P. Bougnoux, C. Vandier, and F. Pierre Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells Biochem. Biophys. Res. Commun. 397 2010 42 47
242. L. Catacuzzeno, B. Fioretti, and F. Franciolini Expression and role of the intermediate-conductance calcium-activated potassium channel KCa3.1 in glioblastoma J. Signal Transduct. 2012 2012 421564
243. A. Cheong, A.J. Bingham, J. Li, B. Kumar, P. Sukumar, C. Munsch, N.J. Buckley, C.B. Neylon, K.E. Porter, D.J. Beech, and I.C. Wood Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation Mol. Cell 20 2005 45 52
244. P. Ruggieri, G. Mangino, B. Fioretti, L. Catacuzzeno, R. Puca, D. Ponti, M. Miscusi, F. Franciolini, G. Ragona, and A. Calogero The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells PLoS ONE 7 2012 e47825
245. + channel mtKCa3.1 Biochim. Biophys. Acta 1797 2010 1260 1267
246. + channel activity Am. J. Physiol. Cell Physiol. 299 2010 C175 C184
247. M. Steinle, D. Palme, M. Misovic, J. Rudner, K. Dittmann, R. Lukowski, P. Ruth, and S.M. Huber Ionizing radiation induces migration of glioblastoma cells by activating BK K(+) channels Radiother. Oncol. 101 2011 122 126
248. A.E. Hegab, T. Sakamoto, A. Nomura, Y. Ishii, Y. Morishima, T. Iizuka, T. Kiwamoto, Y. Matsuno, S. Homma, and K. Sekizawa Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1 Chest 131 2007 1149 1156
249. M.E. Loewen, L.K. Bekar, W. Walz, G.W. Forsyth, and S.E. Gabriel pCLCA1 lacks inherent chloride channel activity in an epithelial colon carcinoma cell line Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G33 G41
250. R.C. Elble, and B.U. Pauli Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium J. Biol. Chem. 276 2001 40510 40517
251. L. Leanza, L. Biasutto, A. Manago, E. Gulbins, M. Zoratti, and I. Szabo Intracellular ion channels and cancer Front. Physiol. 4 2013 227
252. - channels Biochim. Biophys. Acta 1444 1999 418 423
253. F. Gackiere, G. Bidaux, P. Lory, N. Prevarskaya, and P. Mariot A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry? Cell Calcium 39 2006 357 366
254. F. Gackiere, M. Warnier, M. Katsogiannou, S. Derouiche, P. Delcourt, E. Dewailly, C. Slomianny, S. Humez, N. Prevarskaya, M. Roudbaraki, and P. Mariot Functional coupling between large-conductance potassium channels and Cav3.2 voltage-dependent calcium channels participates in prostate cancer cell growth Biol. Open 2 2013 941 951
255. J.P. Chen, Y. Luan, C.X. You, X.H. Chen, R.C. Luo, and R. Li TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2 +) influx Cell Calcium 47 2010 425 432
256. A. Fabian, J. Bertrand, O. Lindemann, T. Pap, and A. Schwab Transient receptor potential canonical channel 1 impacts on mechanosignaling during cell migration Pflugers Arch. 464 2012 623 630
257. A. Fabian, T. Fortmann, E. Bulk, V.C. Bomben, H. Sontheimer, and A. Schwab Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel 1 Pflugers Arch. 461 2011 295 306
258. H.N. Jiang, B. Zeng, Y. Zhang, N. Daskoulidou, H. Fan, J.M. Qu, and S.Z. Xu Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer PLoS ONE 8 2013 e67637
259. P. Sukumaran, C. Lof, I. Pulli, K. Kemppainen, T. Viitanen, and K. Tornquist Significance of the transient receptor potential canonical 2 (TRPC2) channel in the regulation of rat thyroid FRTL-5 cell proliferation, migration, adhesion and invasion Mol. Cell. Endocrinol. 374 2013 10 21
260. H. Saito, Y. Minamiya, H. Watanabe, N. Takahashi, M. Ito, H. Toda, H. Konno, M. Mitsui, S. Motoyama, and J. Ogawa Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung Ann. Surg. Oncol. 18 2011 3377 3383
261. H. Zhang, L. Zhou, W. Shi, N. Song, K. Yu, and Y. Gu A mechanism underlying the effects of polyunsaturated fatty acids on breast cancer Int. J. Mol. Med. 30 2012 487 494
262. A. Guilbert, I. Dhennin-Duthille, Y.E. Hiani, N. Haren, H. Khorsi, H. Sevestre, A. Ahidouch, and H. Ouadid-Ahidouch Expression of TRPC6 channels in human epithelial breast cancer cells BMC Cancer 8 2008 125
263. S. Bernaldo de Quiros, A. Merlo, P. Secades, I. Zambrano, I.S. de Santa Maria, N. Ugidos, E. Jantus-Lewintre, R. Sirera, C. Suarez, and M.D. Chiara Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas BMC Cancer 13 2013 116
264. S. Chigurupati, R. Venkataraman, D. Barrera, A. Naganathan, M. Madan, L. Paul, J.V. Pattisapu, G.A. Kyriazis, K. Sugaya, S. Bushnev, J.D. Lathia, J.N. Rich, and S.L. Chan Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness Cancer Res. 70 2010 418 427
265. G. Santoni, S. Caprodossi, V. Farfariello, S. Liberati, A. Gismondi, and C. Amantini Antioncogenic effects of transient receptor potential vanilloid 1 in the progression of transitional urothelial cancer of human bladder ISRN Urol. 2012 2011 458238
266. J. Waning, J. Vriens, G. Owsianik, L. Stuwe, S. Mally, A. Fabian, C. Frippiat, B. Nilius, and A. Schwab A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration Cell Calcium 42 2007 17 25
267. A. Oulidi, A. Bokhobza, D. Gkika, F. Vanden Abeele, V. Lehen'kyi, L. Ouafik, B. Mauroy, and N. Prevarskaya TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion PLoS ONE 8 2013 e64885
268. M. Nabissi, M.B. Morelli, M. Santoni, and G. Santoni Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents Carcinogenesis 34 2013 48 57
269. L.M. Duncan, J. Deeds, J. Hunter, J. Shao, L.M. Holmgren, E.A. Woolf, R.I. Tepper, and A.W. Shyjan Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis Cancer Res. 58 1998 1515 1520
270. 2 + responses J. Biol. Chem. 287 2012 40924 40937
271. K. Clark, J. Middelbeek, and F.N. van Leeuwen Interplay between TRP channels and the cytoskeleton in health and disease Eur. J. Cell Biol. 87 2008 631 640
272. X. Meng, C. Cai, J. Wu, S. Cai, C. Ye, H. Chen, Z. Yang, H. Zeng, Q. Shen, and F. Zou TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway Cancer Lett. 333 2012 96 102
273. J. Middelbeek, A.J. Kuipers, L. Henneman, D. Visser, I. Eidhof, R. van Horssen, B. Wieringa, S.V. Canisius, W. Zwart, L.F. Wessels, F.C. Sweep, P. Bult, P.N. Span, F.N. van Leeuwen, and K. Jalink TRPM7 is required for breast tumor cell metastasis Cancer Res. 72 2012 4250 4261
274. P. Rybarczyk, M. Gautier, F. Hague, I. Dhennin-Duthille, D. Chatelain, J. Kerr-Conte, F. Pattou, J.M. Regimbeau, H. Sevestre, and H. Ouadid-Ahidouch Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration Int. J. Cancer 131 2012 E851 E861
275. H. Gao, X. Chen, X. Du, B. Guan, Y. Liu, and H. Zhang EGF enhances the migration of cancer cells by up-regulation of TRPM7 Cell Calcium 50 2011 559 568
276. Y. Okamoto, T. Ohkubo, T. Ikebe, and J. Yamazaki Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines Int. J. Oncol. 40 2012 1431 1440
277. G. Bidaux, M. Roudbaraki, C. Merle, A. Crepin, P. Delcourt, C. Slomianny, S. Thebault, J.L. Bonnal, M. Benahmed, F. Cabon, B. Mauroy, and N. Prevarskaya Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement Endocr. Relat. Cancer 12 2005 367 382
278. L.M. Louhivuori, G. Bart, K.P. Larsson, V. Louhivuori, J. Nasman, T. Nordstrom, A.P. Koivisto, and K.E. Akerman Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells J. Cell. Physiol. 221 2009 67 74
279. H. Yamamura, S. Ugawa, T. Ueda, A. Morita, and S. Shimada TRPM8 activation suppresses cellular viability in human melanoma Am. J. Physiol. Cell Physiol. 295 2008 C296 C301
280. N.S. Yee, R.D. Brown, M.S. Lee, W. Zhou, C. Jensen, H. Gerke, and R.K. Yee TRPM8 ion channel is aberrantly expressed and required for preventing replicative senescence in pancreatic adenocarcinoma: potential role of TRPM8 as a biomarker and target Cancer Biol. Ther. 13 2012 592 599
281. 2 +, BK channel activity and cell migration J. Biomed. Sci. 16 2009 90
282. R. Wondergem, T.W. Ecay, F. Mahieu, G. Owsianik, and B. Nilius HGF/SF and menthol increase human glioblastoma cell calcium and migration Biochem. Biophys. Res. Commun. 372 2008 210 215
283. Z.H. Yang, X.H. Wang, H.P. Wang, and L.Q. Hu Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells Asian J. Androl. 11 2009 157 165
284. R.K. Motiani, M.C. Hyzinski-Garcia, X. Zhang, M.M. Henkel, I.F. Abdullaev, Y.H. Kuo, K. Matrougui, A.A. Mongin, and M. Trebak STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion Pflugers Arch. 465 2013 1249 1260
285. N. Yang, Y. Tang, F. Wang, H. Zhang, D. Xu, Y. Shen, S. Sun, and G. Yang Blockade of store-operated Ca(2 +) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover Cancer Lett. 330 2013 163 169
286. R.K. Motiani, I.F. Abdullaev, and M. Trebak A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells J. Biol. Chem. 285 2010 19173 19183